Transforming growth factor beta as endogenous growth inhibitor of chronic lymphocytic leukemia B cells

doi:10.1084/jem.179.3.999

This Article

	Full Text (PDF, 487K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Lotz, M.
	Articles by Kipps, T. J.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Lotz, M.
	Articles by Kipps, T. J.


Social Bookmarking

	What's this?

ARTICLES

Transforming growth factor beta as endogenous growth inhibitor of chronic lymphocytic leukemia B cells

M Lotz, E Ranheim and TJ Kipps
Sam and Rose Stein Institute for Research on Aging, University of California, San Diego, La Jolla 92093.

Chronic lymphocytic leukemia (CLL) B cells are hyporesponsive or refractory to mitogens and growth factors in vitro. This study examined whether transforming growth factor beta (TGF-beta), a potent inhibitor of lymphocyte proliferation may play a role in the growth regulation of CLL B cells. CLL B cells from all donors treated expressed detectable TGF-beta 1 mRNA. In vitro release of TGF-beta by unstimulated cultures, or cultures stimulated by antibody to cell surface immunoglobulin (anti- mu) plus phorbol 12-myristate 13-acetate (PMA) was higher in CLL than in normal B cells. High levels of TGF-beta activity were also detected in plasma samples of CLL patients. The role of TGF-beta in growth regulation of CLL B cells was tested in assays using different B cell activators. Purified neoplastic B cells from most CLL patients proliferated in response to anti-mu, or the combination of anti-mu plus PMA. Levels of CLL B cell proliferation were lower than observed in normal B cells. Some CLL were refractory to these stimuli. Antibody to CD40 induced proliferation of CLL B cells from all donors tested when presented on Fc gamma RII (CDw32)-expressing L cells. Neutralizing antibodies to TGF-beta increased CLL B cell proliferation in the absence or presence of additional stimuli. These effects were dose dependent and specific. Exogenous TGF-beta completely inhibited CLL B cell proliferation induced by anti-mu, PMA, and anti-TGF-beta. CLL B cell proliferation induced by anti-CD40 was reduced by exogenous TGF- beta. However, even at high doses, TGF-beta did not completely inhibit the anti-CD40 effect. In summary, TGF-beta is overexpressed in CLL. CLL B cells are sensitive to TGF-beta and this cytokine functions as an autocrine growth inhibitor accounting at least in part for reduced proliferative responses of these leukemic cells and for the slow progression of the malignant process in vivo.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Fukuda, T., Chen, L., Endo, T., Tang, L., Lu, D., Castro, J. E., Widhopf, G. F. II, Rassenti, L. Z., Cantwell, M. J., Prussak, C. E., Carson, D. A., Kipps, T. J. (2008). Antisera induced by infusions of autologous Ad-CD154-leukemia B cells identify ROR1 as an oncofetal antigen and receptor for Wnt5a. Proc. Natl. Acad. Sci. USA 105: 3047-3052 [Abstract] [Full Text]
Kater, A. P., van Oers, M. H. J., Kipps, T. J. (2007). Cellular immune therapy for chronic lymphocytic leukemia. Blood 110: 2811-2818 [Abstract] [Full Text]
Kaufmann, Y., Amariglio, N., Rosenthal, E., Hirsch, Y. J., Many, A., Rechavi, G. (2005). Proliferation Response of Leukemic Cells to CD70 Ligation Oscillates with Recurrent Remission and Relapse in a Low-Grade Lymphoma. J. Immunol. 175: 6940-6947 [Abstract] [Full Text]
Cerutti, A., Zan, H., Kim, E. C., Shah, S., Schattner, E. J., Schaffer, A., Casali, P. (2002). Ongoing In Vivo Immunoglobulin Class Switch DNA Recombination in Chronic Lymphocytic Leukemia B Cells. J. Immunol. 169: 6594-6603 [Abstract] [Full Text]
Burger, J. A., Tsukada, N., Burger, M., Zvaifler, N. J., Dell'Aquila, M., Kipps, T. J. (2000). Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1. Blood 96: 2655-2663 [Abstract] [Full Text]
Caligaris-Cappio, F., Hamblin, T. J. (1999). B-Cell Chronic Lymphocytic Leukemia: A Bird of a Different Feather. JCO 17: 399-399 [Abstract] [Full Text]
DeCoteau, J. F., Knaus, P. I., Yankelev, H., Reis, M. D., Lowsky, R., Lodish, H. F., Kadin, M. E. (1997). Loss of functional cell surface transforming growth factor beta �(TGF-beta ) type 1�receptor correlates with insensitivity to TGF-beta in chronic lymphocytic�leukemia. Proc. Natl. Acad. Sci. USA 94: 5877-5881 [Abstract] [Full Text]
Cai, J., Zheng, T., Lotz, M., Zhang, Y., Masood, R., Gill, P. (1997). Glucocorticoids Induce Kaposi's Sarcoma Cell Proliferation Through the Regulation of Transforming Growth Factor-beta. Blood 89: 1491-1500 [Abstract] [Full Text]
Douglas, R. S., Capocasale, R. J., Lamb, R. J., Nowell, P. C., Moore, J. S. (1997). Chronic Lymphocytic Leukemia B Cells Are Resistant to the Apoptotic Effects of Transforming Growth Factor-beta. Blood 89: 941-947 [Abstract] [Full Text]